National Institute of Clinical Research
Garden Grove, California 92844
5 studies enrolling now · 13 studies all time
What they study most
Agitation Associated With Alzheimer's Dementia, Alzheimer's Disease, Alzheimer's Disease Psychosis, Autism Spectrum Disorder, Bipolar Disorder, COVID-19, Degenerative Arthritis, Depressive Disorder, Major, End Stage Kidney Disease, Gilteritinib, Healthy Volunteers, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Studies at this site
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia — Recruiting now
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder — Recruiting now
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease — Recruiting now
- ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
- A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH) — Recruiting now
- ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study — Enrolling by invitation
- A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder — Running, not enrolling
- RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee — Running, not enrolling
- A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection — Stopped early
- A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function — Completed
- A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function — Completed
- A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883. — Completed